Three-dimensional ex-vivo visualization of normal and inflamed small intestine and colonic tissue using optical coherence tomography

Inflammatory bowel diseases, including Crohn’s Disease (CD) and Ulcerative Colitis (UC), are characterized by inflammation of the gastrointestinal tract. Early diagnoses are critical in the determination of an effective treatment. Current methods of tissue assessment remain two-dimensional and limited by lack of information under the surface of the mucosal layer. Optical coherence tomography (OCT) is a noninvasive, label-free, volumetric imaging modality which can visualize tissue structures down to the micrometer scale. Previous study has explored OCT as a method for endoscopic and benchtop assessment of colonic tissues. Here, we explore OCT in an ex vivo capacity to visualize features in IBD. Samples from human subjects with normal (not inflamed), UC, and CD diagnoses were imaged, where OCT was able to differentiate between normal ileal and colonic tissue and those from patients with CD or UC. Our study shows the promise of higher-resolution OCT to visualize both small details and overall structures in three-dimensions, informing development of future technologies.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-03-31
DOI
https://doi.org/10.1038/s41598-026-46293-4
Primary Topic
Optical Coherence Tomography Applications
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Three-dimensional ex-vivo visualization of normal and inflamed small intestine and colonic tissue using optical coherence tomography

Parakkal Deepak, Billy D. Nix, Umang Jain, Katherine Huang et al.
Scientific Reports
Optical Coherence Tomography Applications
article

Three-dimensional ex-vivo visualization of normal and inflamed small intestine and colonic tissue using optical coherence tomography

Parakkal Deepak, Billy D. Nix, Umang Jain, Katherine Huang, Ye Li, Changqing Ma, Chao ZHOU, Abigail Matt, Andrew Song
article en

Abstract

Inflammatory bowel diseases, including Crohn’s Disease (CD) and Ulcerative Colitis (UC), are characterized by inflammation of the gastrointestinal tract. Early diagnoses are critical in the determination of an effective treatment. Current methods of tissue assessment remain two-dimensional and limited by lack of information under the surface of the mucosal layer. Optical coherence tomography (OCT) is a noninvasive, label-free, volumetric imaging modality which can visualize tissue structures down to the micrometer scale. Previous study has explored OCT as a method for endoscopic and benchtop assessment of colonic tissues. Here, we explore OCT in an ex vivo capacity to visualize features in IBD. Samples from human subjects with normal (not inflamed), UC, and CD diagnoses were imaged, where OCT was able to differentiate between normal ileal and colonic tissue and those from patients with CD or UC. Our study shows the promise of higher-resolution OCT to visualize both small details and overall structures in three-dimensions, informing development of future technologies.

Scientific Reports
University of Health Sciences and Pharmacy (US), Washington University in St. Louis (US), Universidade do Estado do Pará (BR), Saint Louis University Hospital (US), Wuzhou University (CN), Saint Louis University (US)
Leona M. and Harry B. Helmsley Charitable Trust, Crohn's and Colitis Foundation, National Institutes of Health
Zero hunger
Openalex Percentile: Top 25%
Optical Coherence Tomography Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.